These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stability of nitroglycerin and dobutamine in 5% dextrose and 0.9% sodium chloride injection. Thompson M; Smith M; Gragg R; Soliman KF Am J Hosp Pharm; 1985 Feb; 42(2):361-2. PubMed ID: 3919576 [No Abstract] [Full Text] [Related]
5. [Simplified method of the prevention of the prescription of dobutamine and dopamine]. Juillard A; Barrillon A Nouv Presse Med; 1981 Mar; 70(12):989. PubMed ID: 7208330 [No Abstract] [Full Text] [Related]
6. [Noninvasive monitoring of stroke volume during intravenous infusion of dobutamine]. Gürtler-Krawczyńska E; Pietrzyk E; Pałko T Kardiol Pol; 1983; 26(1):23-32. PubMed ID: 6876530 [No Abstract] [Full Text] [Related]
7. Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine. Cruz KCE; Churchwell MD; Mauro VF; Boddu SHS Am J Health Syst Pharm; 2018 Apr; 75(8):510-512. PubMed ID: 29626000 [No Abstract] [Full Text] [Related]
8. Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside. Schaaf LJ; Tremel LC; Wulf BG; Vernon KK J Clin Pharm Ther; 1990 Oct; 15(5):371-6. PubMed ID: 1963175 [TBL] [Abstract][Full Text] [Related]
9. [Hemodynamic effect of the combined administration of dobutamine and ATP after hemorrhagic shock]. Takekawa K; Sakahira K; Sakanishi N; Tsunoda Y; Yokoyama K; Ikezono E Masui; 1984 Feb; 33(2):131-6. PubMed ID: 6716647 [No Abstract] [Full Text] [Related]
10. [How is catecholamine therapy carried out in heart failure?]. Reek S Dtsch Med Wochenschr; 2002 Oct; 127(40):2087-8. PubMed ID: 12373645 [No Abstract] [Full Text] [Related]
11. Intermittent ambulatory dobutamine infusions for patients awaiting cardiac transplantation. Hodgson JM; Aja M; Sorkin RP Am J Cardiol; 1984 Jan; 53(2):375-6. PubMed ID: 6364757 [No Abstract] [Full Text] [Related]
12. Visual compatibility of dobutamine with seven parenteral drug products. Dahlin PA; Paredes SM Am J Hosp Pharm; 1980 Apr; 37(4):460, 464. PubMed ID: 7377204 [No Abstract] [Full Text] [Related]
13. Visual compatibility of dobutamine hydrochloride with other injectable drugs. Hasegawa GR; Eder JF Am J Hosp Pharm; 1984 May; 41(5):949-51. PubMed ID: 6731457 [No Abstract] [Full Text] [Related]
14. [Comparative effects of dopamine and dobutaine in subendocardial perfusion in the acute phase of myocardial infarct]. Jammet P; Weber S; Degeorges M Ann Med Interne (Paris); 1983; 134(2):139-43. PubMed ID: 6881802 [TBL] [Abstract][Full Text] [Related]
15. Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives. Kirschenbaum HL; Aronoff W; Piltz GW; Perentesis GP; Cutie AJ Am J Hosp Pharm; 1983 Oct; 40(10):1690-1. PubMed ID: 6638033 [No Abstract] [Full Text] [Related]
16. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Fellahi JL; Parienti JJ; Hanouz JL; Plaud B; Riou B; Ouattara A Anesthesiology; 2008 Jun; 108(6):979-87. PubMed ID: 18497597 [TBL] [Abstract][Full Text] [Related]
18. Visual incompatibility of dacarbazine and heparin. Nelson RW; Young R; Lamnin M Am J Hosp Pharm; 1987 Sep; 44(9):2028. PubMed ID: 3674032 [No Abstract] [Full Text] [Related]
19. Stability of dobutamine hydrochloride in selected large-volume parenterals. Kirschenbaum HL; Aronoff W; Perentesis GP; Piltz GW; Goldberg RJ; Cutie AJ Am J Hosp Pharm; 1982 Nov; 39(11):1923-5. PubMed ID: 7148861 [TBL] [Abstract][Full Text] [Related]